Treasury Chief Rachel Reeves Plans Targeted Measures on Living Costs in Forthcoming Financial Plan
Chancellor Rachel Reeves has revealed she is preparing "specific action to tackle household expense issues" in the upcoming financial statement.
During an interview with the BBC, she emphasized that reducing inflation is a shared responsibility of both the government and the central bank.
The United Kingdom's price growth is projected to be the highest among the Group of Seven developed nations this calendar year and next.
Possible Energy Bill Measures
It is understood the government could take action to reduce utility costs, such as by cutting the current 5% level of VAT applied on energy supplies.
Another approach is to lower some of the government charges presently included in household expenses.
Budgetary Constraints and Analyst Expectations
The government will obtain the latest report from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much scope there is for such measures.
The expectation from most experts is that the Chancellor will have to announce tax increases or budget cuts in order to adhere to her declared fiscal targets.
Previously on Thursday, calculations indicated there was a twenty-two billion pound gap for the chancellor to resolve, which is at the lower end of expectations.
"There's a collective task between the Bank of England and the administration to bear down further on some of the causes of inflation," the Chancellor stated to the BBC in Washington, at the conferences of the IMF and global financial institution.
Tax Commitments and Global Issues
While a great deal of the attention has been on likely tax increases, the chancellor said the most recent information from the fiscal watchdog had not altered her pledge to campaign commitments not to raise tax levels on earnings tax, VAT or National Insurance.
She blamed an "unpredictable world" with rising geopolitical and commercial tensions for the fiscal tax moves, probably to be directed on those "wealthiest."
International Trade Disputes
Referring to apprehensions about the UK's economic relations with the Asian nation she said: "Our national security invariably are paramount."
Last week's statement by Chinese authorities to tighten export controls on rare earths and other materials that are crucial for high-technology production led US President the US President to suggest an additional 100% import tax on goods from the Asian country, increasing the risk of an full-scale commercial conflict between the two economic giants.
The American finance chief described China's move "economic coercion" and "a global supply chain power grab."
Questioned on considering the American proposal to participate in its battle with the Asian nation, the Chancellor said she was "very concerned" by China's actions and encouraged the Chinese government "not to put up barriers and restrict access."
She said the decision was "harmful for the world economy and generates further headwinds."
"In my view there are fields where we must confront China, but there are also important chances to sell into China's economy, including banking sector and other sectors of the economy. We've got to achieve that balance appropriate."
The Treasury chief also confirmed she was working with other major economies "regarding our own critical minerals strategy, so that we are reduced dependence."
NHS Medicine Costs and Investment
The Chancellor also recognized that the price the National Health Service pays for medicines could go up as a result of current discussions with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and investment.
A number of the biggest global drug companies have said lately that they are either pausing or canceling investments in the UK, with several attributing the insufficient payments they are obtaining.
Last month, the Science Minister said the price the NHS spends on medicines would have to increase to prevent businesses and pharmaceutical investment departing from the United Kingdom.
Reeves informed the BBC: "It has been observed because of the cost structure, that medical research, new drugs have not been available in the United Kingdom in the manner that they are in other EU nations."
"We want to make sure that people receiving care from the National Health Service are can receive the top life-saving drugs in the globe. And so we are examining this situation, and... looking to attract more funding into the UK."